Most CER Templates Fail at Structure Before Content

Written by HATEM RABEH, MD, MSc Ing

Your Clinical Evaluation Expert And Partner

in
S

Templates are useful. They keep us organized. They remind us what sections to include. But when manufacturers treat a CER template as a checklist to complete rather than a framework to support clinical reasoning, the entire document becomes a compliance exercise that satisfies form but not substance.

The problem is not the template itself. The problem is what gets lost when people focus on filling sections instead of building a logical argument that demonstrates safety and performance based on clinical data.

What MDR Actually Requires from a Clinical Evaluation Report

MDR Article 61 and Annex XIV Part A define the clinical evaluation as a systematic and planned process. The regulation does not prescribe a template. It requires a methodology and a documented conclusion about whether the device meets its intended purpose and whether risks are acceptable.

MDCG 2020-5 offers guidance on the structure. It describes what should be addressed. But even MDCG presents a framework, not a rigid sequence to copy.

Here is what actually matters: the CER must demonstrate a chain of reasoning. It starts with defining the device and its clinical claims. It identifies what clinical data is needed to support those claims. It evaluates that data critically. It appraises the literature systematically. If equivalence is claimed, it demonstrates that equivalence in detail. It identifies gaps. It assesses benefit-risk. It defines what remains to be monitored post-market.

When this chain breaks, no template can fix it.

Why Free Templates Often Create False Confidence

Free CER templates circulate widely. Some come from consulting firms as lead magnets. Others are shared in professional groups. A few are published by academic institutions or industry associations.

Most of these templates include the right section headers. Device description. Intended purpose. State of the art. Clinical data. Literature review. Benefit-risk analysis.

The issue is that these templates rarely explain how to connect these sections into a coherent evaluation. They list what to include, but not how to reason through it.

I see this pattern repeatedly. A manufacturer downloads a template. They populate each section with information. Device specifications go into the device section. Studies go into the clinical data section. Papers go into the literature section. The sections are complete, but they do not speak to each other.

Then the Notified Body asks: How does your state of the art analysis inform which endpoints you evaluated? How does your literature appraisal connect to your benefit-risk conclusion? Why did you consider these comparators and not others?

The template never forced those questions.

What a Functional CER Structure Actually Achieves

A good structure does more than organize information. It guides the evaluator and the reviewer through a logical process.

Start with scope definition. What device are we evaluating? What are its intended clinical benefits? What population will use it? This sets boundaries. Everything that follows must stay within those boundaries or explicitly explain why the scope needs adjustment.

Then state of the art. What do current clinical practice and alternative treatments look like? This is not a general literature review. This is identifying the benchmark against which your device will be judged. If your SOTA is weak or generic, your benefit-risk assessment will lack context.

Next comes identification of necessary clinical data. Based on the device characteristics, claims, and SOTA, what data do you actually need? This is where many CERs lose rigor. Instead of defining what data is necessary, they describe what data is available. Those are not the same thing.

Then appraisal of that data. Clinical investigations if you have them. Equivalence demonstration if you claim it. Literature if it is relevant and sufficient. Each data source must be critically appraised. Not just summarized. Appraised for quality, relevance, and weight.

After that, synthesis. What does the body of evidence tell you about safety and performance? Where are the gaps? Where is uncertainty?

Then benefit-risk. Not a table with checkmarks. A reasoned discussion of whether the benefits justify the risks for the intended population under the intended conditions of use.

Finally, conclusions and post-market monitoring. What did you conclude? What remains uncertain? What must PMCF address?

This sequence is not arbitrary. Each step depends on the previous one. A template that does not enforce this dependency allows disconnection.

The Trap of Compliance-Oriented Templates

Some templates are designed to satisfy checklist-style audits. They include all required sections. They reference all relevant MDCG documents. They use the right terminology.

But compliance is not the same as clinical reasoning.

I have seen CERs that cite MDCG 2020-5, MDCG 2020-6, and MDCG 2020-13 in every section. The citations are correct. But the content does not demonstrate understanding. It demonstrates awareness that these documents exist.

Notified Bodies and competent authorities are not looking for references to guidance documents. They are looking for evidence that you applied the guidance to your specific device.

When a template emphasizes regulatory language over clinical logic, it produces documents that sound compliant but lack substance. Reviewers recognize this immediately.

What to Look for in a CER Template

If you are going to use a template, choose one that supports critical thinking rather than one that enables form-filling.

Look for templates that include guiding questions within each section. Not just headers, but prompts that force you to think. Questions like: What assumptions are you making about equivalence? What alternative explanations exist for the clinical outcomes you observed? What data would change your benefit-risk conclusion?

Look for templates that show relationships between sections. Ideally with visual flow or explicit cross-references. The SOTA should feed into data needs. Data needs should guide appraisal criteria. Appraisal findings should inform benefit-risk.

Look for templates that leave space for uncertainty. Many templates encourage definitive statements in every section. Real clinical evaluation includes acknowledging gaps and explaining how PMCF will address them.

Look for templates that distinguish between different data scenarios. A CER based on own clinical data is structured differently than one based on equivalence. A template that treats these the same forces awkward content.

Avoid templates that include boilerplate text. Pre-written paragraphs about general device safety or regulatory background might save time initially, but they dilute the document and signal to reviewers that the content is generic.

When Templates Become Obstacles

Templates become obstacles when they are too rigid or too vague.

Rigid templates force content into predetermined structures even when the clinical logic does not fit. For example, some templates require a separate section for each MDCG document even when your device does not need equivalence or does not have implant-specific considerations. This creates empty sections or forces irrelevant content.

Vague templates provide section headers without explaining what level of detail or what type of reasoning is expected. A section titled “Clinical Data Analysis” could mean anything from a two-sentence summary to a 40-page statistical evaluation. Without guidance, authors guess. And guessing leads to deficiencies.

The best approach is to use a template as a starting framework, then adapt it based on the device, the available data, and the specific clinical questions that need answers.

If your device has extensive clinical investigation data, expand those sections and reduce reliance on literature. If your device relies on equivalence, the equivalence demonstration becomes the core of the CER and everything else supports it. If your device is well-established but you are introducing a new indication, focus the evaluation on that indication and reference previous evaluations appropriately.

A template should flex to fit the device. Not the other way around.

The Role of Templates in Your Clinical Evaluation Process

Templates are most useful at the planning stage. Before writing the CER, use the template to map out what you need. Which sections will be substantial? Which will be brief? What data do you need to collect before you can complete each section?

During writing, the template keeps you organized. It prevents you from forgetting required elements. It helps maintain structure as the document grows.

But after the first draft, step back from the template. Read the CER as a reviewer would. Does the logic flow? Do the conclusions follow from the evidence? Are there gaps in reasoning?

If the answer is no, the template is not the problem. The clinical reasoning is. And no template will fix that.

Templates also help with updates. When you revise a CER for a new device generation or update it with PMCF data, having a consistent structure makes it easier to identify what changed and what remained the same. Reviewers appreciate continuity.

But again, structure is not substance. Updating a CER is not about filling new information into old sections. It is about re-evaluating clinical safety and performance with additional data.

What Reviewers Actually Look for Beyond Template Compliance

When a Notified Body or competent authority reviews a CER, they do not check whether it follows a template. They assess whether it demonstrates that the device is safe and performs as intended.

They look for clear clinical claims and whether the evidence supports those claims. They look for critical appraisal, not just data summaries. They look for honest acknowledgment of limitations and gaps. They look for benefit-risk reasoning that accounts for the specific patient population and use conditions.

They also look for consistency. Does the intended purpose in the CER match the IFU? Do the clinical claims align with labeling? Does the PMCF plan address the gaps identified in the CER?

None of these things come from a template. They come from understanding your device, understanding the clinical context, and applying MDR requirements with rigor.

A template can help organize that work. It cannot do that work for you.

Moving from Template Dependence to Clinical Reasoning

If your team relies heavily on templates, the goal should be to gradually reduce that dependence.

Start by using the template as a checklist of topics to address, not as a document to fill in. Outline your clinical reasoning first. Identify the key questions your CER must answer. Then map those questions to the template structure.

Train your team to think in terms of evidence chains. What do we claim? What evidence supports it? How strong is that evidence? What could challenge it? What remains uncertain?

When you review draft CERs, do not check whether sections are complete. Check whether the reasoning is sound. Ask: If I were the reviewer, what would I question? If the answers are not already in the document, the structure is irrelevant.

Over time, your team will internalize the logic of clinical evaluation. The template becomes a convenience, not a crutch.

Final Considerations on Templates and Real Evaluation

Templates are tools. Like any tool, they are useful when applied correctly and counterproductive when misused.

If you are looking for a CER template, choose one that supports thinking rather than one that enables box-checking. Adapt it to your device. Question it when it does not fit.

But more importantly, invest in understanding what a clinical evaluation actually requires. Read MDR Annex XIV carefully. Study MDCG 2020-5 not as a checklist but as a description of reasoning. Review your own past CERs and ask what the reviewers were really questioning.

Because the goal is not to have a perfect template. The goal is to produce a clinical evaluation that demonstrates, with evidence and logic, that your device is safe and performs as intended.

And that cannot be downloaded.

Peace,
Hatem
Clinical Evaluation Expert for Medical Devices
Follow me for more insights and practical advice.